SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stressgen (VSE: SSB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Marsh who wrote (12)3/27/1997 11:40:00 AM
From: j bell   of 236
 
there is a very postitive article on the company in the Globe and Mail today.
.analysts quoted as saying the stock will bottom around 4.50 and then head up.There are details about the joint venture with Genzyme Corp .Each partner to have 50% interest in joint venture to fight cancer using body' own immune cells

Article also reports an injection of 10 million from the Canada Medical Discovery Fund and plans to secure another ten million in investment.
Analsysts say profit taking may behind the price softening after the deal was announced.
The Bre X factor was not mentioned ..but many speculative stocks are going down in sympathy with that company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News